StockData
Liquidia Corp logo

Liquidia Corp (LQDA) stock

LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.73+0.36 (+0.64%)

Close on Nov 17, 2026Market cap $5.08BP/E 40.8Yield –

Liquidia total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Liquidia's total debt was $19.88M at Dec 31, 2022. For fiscal 2022 it was $19.88M, up 91.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$19.88M+91.0%
FY2021Dec 31, 2021$10.41M+1.1%
FY2020Dec 31, 2020$10.29M-35.2%
FY2019Dec 31, 2019$15.88M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$19.88M+91.0%
Q3 FY2022Sep 30, 2022$19.74M+91.1%
Q2 FY2022Jun 30, 2022$19.61M+91.2%
Q1 FY2022Mar 31, 2022$19.48M+91.4%
Q4 FY2021Dec 31, 2021$10.41M+1.1%
Q3 FY2021Sep 30, 2021$10.33M-34.9%
Q2 FY2021Jun 30, 2021$10.25M–
Q1 FY2021Mar 31, 2021$10.18M–
Q4 FY2020Dec 31, 2020$10.29M–
Q4 FY2019Dec 31, 2019$15.88M–

More Liquidia figures

See a number that looks wrong?